NCT06912087 2025-12-02
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
University of Chicago
Phase 1 Recruiting
University of Chicago
Shandong Cancer Hospital and Institute
Royal Marsden NHS Foundation Trust
Fujian Medical University Union Hospital
Danish Breast Cancer Cooperative Group